v3.25.2
SEGMENTS, GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA (Schedule Of Financial Information With Respect To Single Operating Segment) (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total revenues $ 3,541 $ 9,261
Financial income, net (2,315) (2,528)
Taxes on income 14 14
Net loss (14,523) (9,390)
Single Operating Segment [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total revenues 3,541 9,261
Preclinical R&D expenses 6,659 8,546
Clinical R&D expenses 6,982 7,107
SG&A 4,851 4,592
Financial income, net (2,314) (2,528)
Taxes on income 14 14
Other segment expenses [1] 1,872 920
Net loss $ (14,523) $ (9,390)
[1] Other segment expense (income) during the six months ended June 30, 2025 and 2024 includes property and equipment depreciation, GS-0321 asset of set-up activities, share-based compensation and other adjustments.